Skip to main content

Peer Review reports

From: Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

Original Submission
12 Aug 2020 Submitted Original manuscript
25 Oct 2020 Reviewed Reviewer Report
18 Nov 2020 Reviewed Reviewer Report - Yesim Tuncok
8 Jan 2021 Author responded Author comments - Robert Dobbins
Resubmission - Version 2
8 Jan 2021 Submitted Manuscript version 2
31 Mar 2021 Author responded Author comments - Robert Dobbins
Resubmission - Version 3
31 Mar 2021 Submitted Manuscript version 3
20 Apr 2021 Reviewed Reviewer Report - Yesim Tuncok
1 May 2021 Reviewed Reviewer Report
7 May 2021 Author responded Author comments - Robert Dobbins
Resubmission - Version 4
7 May 2021 Submitted Manuscript version 4
19 May 2021 Author responded Author comments - Robert Dobbins
Resubmission - Version 5
19 May 2021 Submitted Manuscript version 5
Publishing
20 May 2021 Editorially accepted
13 Jun 2021 Article published 10.1186/s40360-021-00502-0

You can find further information about peer review here.

Back to article page